Immunocore Holdings plc

NasdaqGS:IMCR 株式レポート

時価総額:US$1.6b

Immunocore Holdings バランスシートの健全性

財務の健全性 基準チェック /66

Immunocore Holdingsの総株主資本は$377.8M 、総負債は$438.7Mで、負債比率は116.1%となります。総資産と総負債はそれぞれ$1.1Bと$706.8Mです。

主要情報

116.1%

負債資本比率

US$438.70m

負債

インタレスト・カバレッジ・レシオn/a
現金US$901.28m
エクイティUS$377.83m
負債合計US$706.81m
総資産US$1.08b

財務の健全性に関する最新情報

Recent updates

Is Immunocore Holdings (NASDAQ:IMCR) Using Debt Sensibly?

Oct 24
Is Immunocore Holdings (NASDAQ:IMCR) Using Debt Sensibly?

Immunocore Holdings plc's (NASDAQ:IMCR) Business And Shares Still Trailing The Industry

Sep 19
Immunocore Holdings plc's (NASDAQ:IMCR) Business And Shares Still Trailing The Industry

Immunocore Holdings: KIMMTRAK Success, Diverse Pipeline, And Potential Big Pharma Appeal

Aug 12

Is Immunocore Holdings plc (NASDAQ:IMCR) Trading At A 33% Discount?

Jul 24
Is Immunocore Holdings plc (NASDAQ:IMCR) Trading At A 33% Discount?

Immunocore Holdings plc's (NASDAQ:IMCR) 28% Dip In Price Shows Sentiment Is Matching Revenues

Jun 16
Immunocore Holdings plc's (NASDAQ:IMCR) 28% Dip In Price Shows Sentiment Is Matching Revenues

Is Immunocore Holdings (NASDAQ:IMCR) Using Debt Sensibly?

May 11
Is Immunocore Holdings (NASDAQ:IMCR) Using Debt Sensibly?

Immunocore Holdings plc (NASDAQ:IMCR) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

May 11
Immunocore Holdings plc (NASDAQ:IMCR) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Are Investors Undervaluing Immunocore Holdings plc (NASDAQ:IMCR) By 25%?

Apr 05
Are Investors Undervaluing Immunocore Holdings plc (NASDAQ:IMCR) By 25%?

Here's Why Immunocore Holdings (NASDAQ:IMCR) Can Manage Its Debt Despite Losing Money

Jan 22
Here's Why Immunocore Holdings (NASDAQ:IMCR) Can Manage Its Debt Despite Losing Money

Immunocore Holdings: Vulnerable To Profit Taking After Big Rally

Jan 21

Revenues Not Telling The Story For Immunocore Holdings plc (NASDAQ:IMCR) After Shares Rise 37%

Dec 18
Revenues Not Telling The Story For Immunocore Holdings plc (NASDAQ:IMCR) After Shares Rise 37%

Some Confidence Is Lacking In Immunocore Holdings plc's (NASDAQ:IMCR) P/S

May 08
Some Confidence Is Lacking In Immunocore Holdings plc's (NASDAQ:IMCR) P/S

Forecast: Analysts Think Immunocore Holdings plc's (NASDAQ:IMCR) Business Prospects Have Improved Drastically

Nov 16
Forecast: Analysts Think Immunocore Holdings plc's (NASDAQ:IMCR) Business Prospects Have Improved Drastically

Immunocore: Attractive Commercial-Stage Biopharma

Oct 05

Need To Know: Analysts Are Much More Bullish On Immunocore Holdings plc (NASDAQ:IMCR)

Aug 12
Need To Know: Analysts Are Much More Bullish On Immunocore Holdings plc (NASDAQ:IMCR)

Immunocore GAAP EPS of -$0.17, revenue of $38.92M

Aug 10

Immunocore to raise $140M in private placement financing

Jul 18

財務状況分析

短期負債: IMCRの 短期資産 ( $1.0B ) が 短期負債 ( $266.2M ) を超えています。

長期負債: IMCRの短期資産 ( $1.0B ) が 長期負債 ( $440.6M ) を上回っています。


デット・ツー・エクイティの歴史と分析

負債レベル: IMCR総負債よりも多くの現金を保有しています。

負債の削減: IMCRの負債対資本比率は、過去 5 年間で197.8%から116.1%に減少しました。


貸借対照表


キャッシュ・ランウェイ分析

過去に平均して赤字であった企業については、少なくとも1年間のキャッシュ・ランウェイがあるかどうかを評価する。

安定したキャッシュランウェイ: 利益は出ていないものの、 IMCRは現在のプラスの フリーキャッシュフロー レベルを維持すれば、3 年以上は十分な キャッシュランウェイ を有しています。

キャッシュランウェイの予測: IMCRは利益は出ていませんが、フリーキャッシュフローがプラスであり、年間36.1 % 増加しているため、3 年以上は十分なキャッシュランウェイがあります。


健全な企業の発掘